Marisol Salgado-Albarrán
Research Subjects
Research Interests
Marisol Salgado-Albarrán has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Ernesto Soto-Reyes
Departamento de Ciencias Naturales, Universidad Autónoma Metropolitana-Cuajimalpa (UAM-C), Mexico City, Mexico
5 shared publications - Jan Baumbach
Institute for Computational Systems Biomedicine, University of Hamburg , Hamburg 22761
5 shared publications - Nicolas Alcaraz
Center for Epigenetic Cell Memory (EpiC), Danish Cancer Institute, Danish Cancer Society, Copenhagen 2100, Denmark
3 shared publications - Rodrigo González-Barrios
Laboratorio de Regulación de la Cromatina y Genómica, Instituto Nacional de Cancerología , Mexico City, 14080
3 shared publications Alejandro García-Carrancá
Cancer Biomedical Research Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico
2 shared publications- Aylin Del Moral-Morales
DIFACQUIM Research Group, Deparment of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de Mexico
2 shared publications
Latest Publications
- Open Access
CTCF and Its Multi-Partner Network for Chromatin Regulation
Architectural proteins are essential epigenetic regulators that play a critical role in organizing chromatin and controlling gene expression. CTCF (CCCTC-binding factor) is a key architectural protein responsible for maintaining the intricate 3D structure of chromatin. Because of its multivalent properties and plasticity to bind various sequences, CTCF is similar to a Swiss knife for genome organization. Despite the importance of this protein, its mechanisms of action are not fully elucidated. It has been hypothesized that its versatility is achieved through interaction with multiple partners, forming a complex network that regulates chromatin folding within the nucleus. In this review, we delve into CTCF’s interactions with other molecules involved in epigenetic processes, particularly histone and DNA demethylases, as well as several long non-coding RNAs (lncRNAs) that are able to recruit CTCF. Our review highlights the importance of CTCF partners to shed light on chromatin regulation and pave the way for future exploration of the mechanisms that enable the finely-tuned role of CTCF as a master regulator of chromatin.
Open AccessCTCF and Its Multi-Partner Network for Chromatin Regulation
Architectural proteins are essential epigenetic regulators that play a critical role in organizing chromatin and controlling gene expression. CTCF (CCCTC-binding factor) is a key architectural protein responsible for maintaining the intricate 3D structure of chromatin. Because of its multivalent properties and plasticity to bind various sequences, CTCF is similar to a Swiss knife for genome organization. Despite the importance of this protein, its mechanisms of action are not fully elucidated. It has been hypothesized that its versatility is achieved through interaction with multiple partners, forming a complex network that regulates chromatin folding within the nucleus. In this review, we delve into CTCF’s interactions with other molecules involved in epigenetic processes, particularly histone and DNA demethylases, as well as several long non-coding RNAs (lncRNAs) that are able to recruit CTCF. Our review highlights the importance of CTCF partners to shed light on chromatin regulation and pave the way for future exploration of the mechanisms that enable the finely-tuned role of CTCF as a master regulator of chromatin.
- Open Access
- 26 August 2022
- Published by ScienceOpen
Targeting infectious diseases: The CoVex example
In a pandemic, such as the one caused by the coronavirus in 2020, fast action is required to provide insights into the disease mechanisms and to find potential drug targets to slow the progress of the disease and lower mortality. We developed CoVex, an interactive online platform for the exploration of the SARS-CoV-2 host interactome and the identification of drug candidates. CoVex integrates the virus-human protein interactions, human protein-protein interactions, and drug-target interactions, and allows for visual exploration of the data. The exploration is guided by network-based systems medicine algorithms that enable the assembly of ranked lists of candidates for already approved drugs. Unlike novel drugs, approved drugs have the advantage that most of their side effects and contraindications are known. Additionally, they are already available and can be distributed quickly, which makes them promising candidates to stop the uncontrolled spread of the disease early. CoVex is an example of how this could be achieved in future pandemics and provides valuable lessons on what is required in such a situation to maximize the potential of computational approaches that can significantly speed up drug discovery.
- 26 August 2022
- Published by ScienceOpen
Open AccessTargeting infectious diseases: The CoVex example
In a pandemic, such as the one caused by the coronavirus in 2020, fast action is required to provide insights into the disease mechanisms and to find potential drug targets to slow the progress of the disease and lower mortality. We developed CoVex, an interactive online platform for the exploration of the SARS-CoV-2 host interactome and the identification of drug candidates. CoVex integrates the virus-human protein interactions, human protein-protein interactions, and drug-target interactions, and allows for visual exploration of the data. The exploration is guided by network-based systems medicine algorithms that enable the assembly of ranked lists of candidates for already approved drugs. Unlike novel drugs, approved drugs have the advantage that most of their side effects and contraindications are known. Additionally, they are already available and can be distributed quickly, which makes them promising candidates to stop the uncontrolled spread of the disease early. CoVex is an example of how this could be achieved in future pandemics and provides valuable lessons on what is required in such a situation to maximize the potential of computational approaches that can significantly speed up drug discovery.
- Open Access
- 24 May 2021
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 7 (1) , 1-14
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection
COVID-19 is an infection caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2), which has caused a global outbreak. Current research efforts are focused on the understanding of the molecular mechanisms involved in SARS-CoV-2 infection in order to propose drug-based therapeutic options. Transcriptional changes due to epigenetic regulation are key host cell responses to viral infection and have been studied in SARS-CoV and MERS-CoV; however, such changes are not fully described for SARS-CoV-2. In this study, we analyzed multiple transcriptomes obtained from cell lines infected with MERS-CoV, SARS-CoV, and SARS-CoV-2, and from COVID-19 patient-derived samples. Using integrative analyses of gene co-expression networks and de-novo pathway enrichment, we characterize different gene modules and protein pathways enriched with Transcription Factors or Epifactors relevant for SARS-CoV-2 infection. We identified EP300, MOV10, RELA, and TRIM25 as top candidates, and more than 60 additional proteins involved in the epigenetic response during viral infection that has therapeutic potential. Our results show that targeting the epigenetic machinery could be a feasible alternative to treat COVID-19.
- 24 May 2021
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 7 (1) , 1-14
Open AccessComparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection
COVID-19 is an infection caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2), which has caused a global outbreak. Current research efforts are focused on the understanding of the molecular mechanisms involved in SARS-CoV-2 infection in order to propose drug-based therapeutic options. Transcriptional changes due to epigenetic regulation are key host cell responses to viral infection and have been studied in SARS-CoV and MERS-CoV; however, such changes are not fully described for SARS-CoV-2. In this study, we analyzed multiple transcriptomes obtained from cell lines infected with MERS-CoV, SARS-CoV, and SARS-CoV-2, and from COVID-19 patient-derived samples. Using integrative analyses of gene co-expression networks and de-novo pathway enrichment, we characterize different gene modules and protein pathways enriched with Transcription Factors or Epifactors relevant for SARS-CoV-2 infection. We identified EP300, MOV10, RELA, and TRIM25 as top candidates, and more than 60 additional proteins involved in the epigenetic response during viral infection that has therapeutic potential. Our results show that targeting the epigenetic machinery could be a feasible alternative to treat COVID-19.
- 14 January 2021
- Published by Springer Nature in Nature Computational Science
- Vol. 1 (1) , 33-41
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
- 14 January 2021
- Published by Springer Nature in Nature Computational Science
- Vol. 1 (1) , 33-41
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
- Open Access
- 12 August 2019
- Published by Springer Nature in Oncogenesis
- Vol. 8 (8) , 1-12
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
The identification of prognostic biomarkers is a priority for patients suffering from high-grade serous ovarian cancer (SOC), which accounts for >70% of ovarian cancer (OC) deaths. Meanwhile, borderline ovarian cancer (BOC) is a low malignancy tumor and usually patients undergo surgery with low probabilities of recurrence. However, SOC remains the most lethal neoplasm due to the lack of biomarkers for early diagnosis and prognosis. In this regard, BORIS (CTCFL), a CTCF paralog, is a promising cancer biomarker that is overexpressed and controls transcription in several cancer types, mainly in OC. Studies suggest that BORIS has an important function in OC by altering gene expression, but the effect and extent to which BORIS influences transcription in OC from a genome-wide perspective is unclear. Here, we sought to identify BORIS target genes in an OC cell line (OVCAR3) with potential biomarker use in OC tumor samples. To achieve this, we performed in vitro knockout and knockdown experiments of BORIS in OVCAR3 cell line followed by expression microarrays and bioinformatics network enrichment analysis to identify relevant BORIS target genes. In addition, ex vivo expression data analysis of 373 ovarian cancer patients were evaluated to identify the expression patterns of BORIS target genes. In vitro, we uncovered 130 differentially expressed genes and obtained the BORIS-associated regulatory network, in which the androgen receptor (AR) acts as a major transcription factor. Also, FN1, FAM129A, and CD97 genes, which are related to chemoresistance and metastases in OC, were identified. In SOC patients, we observed that malignancy is associated with high levels of BORIS expression while BOC patients show lower levels. Our study suggests that BORIS acts as a main regulator, and has the potential to be used as a prognostic biomarker and to yield novel drug targets among the genes BORIS controls in SOC patients.
- 12 August 2019
- Published by Springer Nature in Oncogenesis
- Vol. 8 (8) , 1-12
Open AccessThe epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
The identification of prognostic biomarkers is a priority for patients suffering from high-grade serous ovarian cancer (SOC), which accounts for >70% of ovarian cancer (OC) deaths. Meanwhile, borderline ovarian cancer (BOC) is a low malignancy tumor and usually patients undergo surgery with low probabilities of recurrence. However, SOC remains the most lethal neoplasm due to the lack of biomarkers for early diagnosis and prognosis. In this regard, BORIS (CTCFL), a CTCF paralog, is a promising cancer biomarker that is overexpressed and controls transcription in several cancer types, mainly in OC. Studies suggest that BORIS has an important function in OC by altering gene expression, but the effect and extent to which BORIS influences transcription in OC from a genome-wide perspective is unclear. Here, we sought to identify BORIS target genes in an OC cell line (OVCAR3) with potential biomarker use in OC tumor samples. To achieve this, we performed in vitro knockout and knockdown experiments of BORIS in OVCAR3 cell line followed by expression microarrays and bioinformatics network enrichment analysis to identify relevant BORIS target genes. In addition, ex vivo expression data analysis of 373 ovarian cancer patients were evaluated to identify the expression patterns of BORIS target genes. In vitro, we uncovered 130 differentially expressed genes and obtained the BORIS-associated regulatory network, in which the androgen receptor (AR) acts as a major transcription factor. Also, FN1, FAM129A, and CD97 genes, which are related to chemoresistance and metastases in OC, were identified. In SOC patients, we observed that malignancy is associated with high levels of BORIS expression while BOC patients show lower levels. Our study suggests that BORIS acts as a main regulator, and has the potential to be used as a prognostic biomarker and to yield novel drug targets among the genes BORIS controls in SOC patients.
- Open Access
- 2 April 2019
- Published by Wiley in Molecular Oncology
- Vol. 13 (5) , 1249-1267
New insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR
Radioresistance of tumor cells gives rise to local recurrence and disease progression in many patients. MicroRNAs (miRNAs) are master regulators of gene expression that control oncogenic pathways to modulate the radiotherapy response of cells. In the present study, differential expression profiling assays identified 16 deregulated miRNAs in acquired radioresistant breast cancer cells, of which miR‐122 was observed to be up‐regulated. Functional analysis revealed that miR‐122 has a role as a tumor suppressor in parental cells by decreasing survival and promoting radiosensitivity. However, in radioresistant cells, miR‐122 functions as an oncomiR by promoting survival. The transcriptomic landscape resulting from knockdown of miR‐122 in radioresistant cells showed modulation of the ZNF611, ZNF304, RIPK1, HRAS, DUSP8 and TNFRSF21 genes. Moreover, miR‐122 and the set of affected genes were prognostic factors in breast cancer patients treated with radiotherapy. Our data indicate that up‐regulation of miR‐122 promotes cell survival in acquired radioresistant breast cancer and also suggest that miR‐122 differentially controls the response to radiotherapy by a dual function as a tumor suppressor an and oncomiR dependent on cell phenotype.
- 2 April 2019
- Published by Wiley in Molecular Oncology
- Vol. 13 (5) , 1249-1267
Open AccessNew insights into radioresistance in breast cancer identify a dual function of miR‐122 as a tumor suppressor and oncomiR
Radioresistance of tumor cells gives rise to local recurrence and disease progression in many patients. MicroRNAs (miRNAs) are master regulators of gene expression that control oncogenic pathways to modulate the radiotherapy response of cells. In the present study, differential expression profiling assays identified 16 deregulated miRNAs in acquired radioresistant breast cancer cells, of which miR‐122 was observed to be up‐regulated. Functional analysis revealed that miR‐122 has a role as a tumor suppressor in parental cells by decreasing survival and promoting radiosensitivity. However, in radioresistant cells, miR‐122 functions as an oncomiR by promoting survival. The transcriptomic landscape resulting from knockdown of miR‐122 in radioresistant cells showed modulation of the ZNF611, ZNF304, RIPK1, HRAS, DUSP8 and TNFRSF21 genes. Moreover, miR‐122 and the set of affected genes were prognostic factors in breast cancer patients treated with radiotherapy. Our data indicate that up‐regulation of miR‐122 promotes cell survival in acquired radioresistant breast cancer and also suggest that miR‐122 differentially controls the response to radiotherapy by a dual function as a tumor suppressor an and oncomiR dependent on cell phenotype.
- Open Access
- 30 March 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (24) , 17028-17042
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
- 30 March 2018
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (24) , 17028-17042
Open AccessCTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
- Open Access
- 1 June 2015
- Published by Universidad Nacional Autonoma de Mexico in TIP Revista Especializada en Ciencias Químico-Biológicas
- Vol. 18 (1) , 43-51
Caracterización de patrones de hordeínas en variedades mexicanas de cebada maltera
ResumenUn grupo de proteínas de almacenamiento muy abundantes en la semilla de cereales son las prolaminas que se caracterizan por contener muchos residuos de prolina en su secuencia. En cebada, las prolaminas son denominadas hordeínas. El propósito de este estudio fue obtener los patrones proteicos de bandeo mediante la técnica de electroforesis en gel de poliacrilamida bajo condiciones desnaturalizantes para, hordeínas de semilla seca de cinco variedades mexicanas de cebada. Asimismo, se obtuvieron los patrones de hordeínas en malta procesada a partir de cuatro variedades mexicanas y una variedad canadiense (Metcalfe). A continuación, algunas de las bandas diferenciales fueron identificadas mediante espectrometría de masas (EM) utilizando distintos protocolos de digestión. En los patrones de semilla seca se encontraron diferencias entre las variedades mexicanas para las bandas correspondientes a un peso molecular de 100 kDa, 65 kDa y algunas de 37-45 kDa. En el caso de la malta, los patrones de las variedades mexicanas fueron muy contrastantes entre sí, así como con el observado en Metcalfe, lo que sugiere que el procesamiento de hordeínas durante la germinación y el secado de la malta depende de cada variedad. Finalmente, en la identificación por EM se demostró que el uso de digestión con tripsina es adecuado para distinguir hordeínas B y γ en malta, mientras que el uso de digestión secuencial con quimotripsina y tripsina favorece la identificación de hordeínas C en semilla seca.AbstractA group of storage proteins highly abundant in cereal seeds are the prolamins, characterized by the frequent presence of proline in their sequence. The barley prolamins are known as hordeins. The aim of this study was to obtain the hordein banding patterns for five different Mexican barley cultivars in mature seeds. In addition, the hordein patterns in processed malt of four mexican and a canadian (Metcalfe) barley cultivars were obtained. Mass Spectrometry (MS), using distinct digestion protocols, identified differential bands in the patterns. Major differences in the seed patterns between cultivars consisted in discrete bands at 100 kDa, 65 kDa and in the range of 37 to 45 kDa. In malt, the patterns were highly contrasting among Mexican cultivars as well as in Metcalfe, suggesting that hordein processing during germination and malt processing is particular to each cultivar. Finally, the MS identification demonstrated that trypsin digestion is appropriate to distinguish B and γ hordeins in malt, whereas sequential digestion with chymotrypsin and trypsin allows the identification of C hordeins in seed
- 1 June 2015
- Published by Universidad Nacional Autonoma de Mexico in TIP Revista Especializada en Ciencias Químico-Biológicas
- Vol. 18 (1) , 43-51
Open AccessCaracterización de patrones de hordeínas en variedades mexicanas de cebada maltera
ResumenUn grupo de proteínas de almacenamiento muy abundantes en la semilla de cereales son las prolaminas que se caracterizan por contener muchos residuos de prolina en su secuencia. En cebada, las prolaminas son denominadas hordeínas. El propósito de este estudio fue obtener los patrones proteicos de bandeo mediante la técnica de electroforesis en gel de poliacrilamida bajo condiciones desnaturalizantes para, hordeínas de semilla seca de cinco variedades mexicanas de cebada. Asimismo, se obtuvieron los patrones de hordeínas en malta procesada a partir de cuatro variedades mexicanas y una variedad canadiense (Metcalfe). A continuación, algunas de las bandas diferenciales fueron identificadas mediante espectrometría de masas (EM) utilizando distintos protocolos de digestión. En los patrones de semilla seca se encontraron diferencias entre las variedades mexicanas para las bandas correspondientes a un peso molecular de 100 kDa, 65 kDa y algunas de 37-45 kDa. En el caso de la malta, los patrones de las variedades mexicanas fueron muy contrastantes entre sí, así como con el observado en Metcalfe, lo que sugiere que el procesamiento de hordeínas durante la germinación y el secado de la malta depende de cada variedad. Finalmente, en la identificación por EM se demostró que el uso de digestión con tripsina es adecuado para distinguir hordeínas B y γ en malta, mientras que el uso de digestión secuencial con quimotripsina y tripsina favorece la identificación de hordeínas C en semilla seca.AbstractA group of storage proteins highly abundant in cereal seeds are the prolamins, characterized by the frequent presence of proline in their sequence. The barley prolamins are known as hordeins. The aim of this study was to obtain the hordein banding patterns for five different Mexican barley cultivars in mature seeds. In addition, the hordein patterns in processed malt of four mexican and a canadian (Metcalfe) barley cultivars were obtained. Mass Spectrometry (MS), using distinct digestion protocols, identified differential bands in the patterns. Major differences in the seed patterns between cultivars consisted in discrete bands at 100 kDa, 65 kDa and in the range of 37 to 45 kDa. In malt, the patterns were highly contrasting among Mexican cultivars as well as in Metcalfe, suggesting that hordein processing during germination and malt processing is particular to each cultivar. Finally, the MS identification demonstrated that trypsin digestion is appropriate to distinguish B and γ hordeins in malt, whereas sequential digestion with chymotrypsin and trypsin allows the identification of C hordeins in seed